1. Home
  2. NICE vs INDV Comparison

NICE vs INDV Comparison

Compare NICE & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NICE Ltd

NICE

NICE Ltd

HOLD

Current Price

$104.68

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$34.85

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NICE
INDV
Founded
1986
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
4.7B
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
NICE
INDV
Price
$104.68
$34.85
Analyst Decision
Buy
Analyst Count
13
0
Target Price
$153.46
N/A
AVG Volume (30 Days)
345.7K
1.5M
Earning Date
05-14-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8100.00
EPS
N/A
1.67
Revenue
N/A
$1,239,000,000.00
Revenue This Year
$10.14
N/A
Revenue Next Year
$9.62
N/A
P/E Ratio
$11.21
$21.37
Revenue Growth
N/A
4.29
52 Week Low
$83.10
$22.30
52 Week High
$153.07
$42.81

Technical Indicators

Market Signals
Indicator
NICE
INDV
Relative Strength Index (RSI) 53.13 42.27
Support Level $96.03 $32.06
Resistance Level $104.84 $35.54
Average True Range (ATR) 3.52 0.86
MACD -0.08 0.17
Stochastic Oscillator 52.22 55.79

Price Performance

Historical Comparison
NICE
INDV

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: